Modeling pediatric low-grade glioma heterogeneity using human forebrain organoids

Pediatric low-grade gliomas (pLGGs) are the most common type of brain tumors in children, characterized by their typically slow growth and oncogene-induced senescence. Preclinical models provide the opportunity to investigate the effects of various treatments in a controlled setting before they are tested in human patients; however, reliable models for pLGGs are limited. Here we developed two organoid models for pLGGs, which, after engraftment into mice, exhibited low-grade features. Furthermore, the genome-wide DNA methylation and RNA profiles of the organoids demonstrated closer similarity to low-grade glioma entities compared to high-grade counterparts. Additionally, pLGG organoid-derived cells align with oligodendrocyte-like, astrocyte-like and MAPK signature clusters seen in patient tumors, indicating that the organoids generate a heterogeneous population of cancer cells, where cellular diversity may influence disease progression and treatment response.

Authors

Institutions

Publication Details

Journal
Molecular Cancer
Published
2026-04-01
DOI
https://doi.org/10.1186/s12943-026-02612-x
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Modeling pediatric low-grade glioma heterogeneity using human forebrain organoids

Toma Tebaldi, Luca Tiberi, Marina Cardano, Chiara Lago et al.
Molecular Cancer
Glioma Diagnosis and Treatment
article

Modeling pediatric low-grade glioma heterogeneity using human forebrain organoids

Toma Tebaldi, Luca Tiberi, Marina Cardano, Chiara Lago, Lucia Santomaso, Luana Abballe, Davide Pernici, Matteo Gianesello, Celeste Antonacci, Francesco Antonica, Francesca Romana Buttarelli, Manila Antonelli, Linda Petrucci, Simone Minasi, Emma Busarello, Alessia Soldano, Sara Patrizi, G. Leva, Noemi Pozza, Federica Ress, Gabriele Trentini, Elisabetta Ferretti, Francesca Gianno, Federico Cocchini, Evelina Miele, Martina Iannuzzi
article en

Abstract

Pediatric low-grade gliomas (pLGGs) are the most common type of brain tumors in children, characterized by their typically slow growth and oncogene-induced senescence. Preclinical models provide the opportunity to investigate the effects of various treatments in a controlled setting before they are tested in human patients; however, reliable models for pLGGs are limited. Here we developed two organoid models for pLGGs, which, after engraftment into mice, exhibited low-grade features. Furthermore, the genome-wide DNA methylation and RNA profiles of the organoids demonstrated closer similarity to low-grade glioma entities compared to high-grade counterparts. Additionally, pLGG organoid-derived cells align with oligodendrocyte-like, astrocyte-like and MAPK signature clusters seen in patient tumors, indicating that the organoids generate a heterogeneous population of cancer cells, where cellular diversity may influence disease progression and treatment response.

Molecular Cancer
Scuola Internazionale Superiore di Studi Avanzati (IT), University of Trento (IT), Yale Cancer Center (US), Istituto Neurologico Mediterraneo (IT), Bambino Gesù Children's Hospital (IT), Sapienza University of Rome (IT)
European Science Foundation, EMBO, Associazione Italiana per la Ricerca sul Cancro
Good health and well-being
Openalex Percentile: Top 30%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.